Game-changing cancer test means I met my granddaughter
Summary
A new blood test being trialed in Wales, called QuicDNA, has shown promise in helping patients with advanced lung cancer, like Pat Grant, respond to treatment. This test could soon become a standard method in NHS Wales for diagnosing and managing various late-stage cancers. The initiative has gained support and funding to expand its availability to other cancer types, benefiting patients like Craig Maxwell.Key Facts
- Pat Grant, diagnosed with inoperable lung cancer, participated in a trial for a new blood test and found hope with specific medication.
- The test, called QuicDNA, is being introduced as a standard diagnostic tool for late-stage lung cancer in NHS Wales.
- The test helped Pat Grant feel stronger and allowed her to meet her grandchild.
- Funding from Welsh and UK governments is helping expand the test to other cancer types like colorectal and prostate.
- Craig Maxwell, another patient, raised £1.7 million to support the QuicDNA project after benefiting from it himself.
- The project funding supports research and the development of further treatments for other cancer patients.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.